Reportable Segments | Segment Information: Effective January 1, 2016, our former Performance Chemicals reportable segment was split into two reportable segments: (1) Lithium and Advanced Materials and (2) Bromine Specialties. In addition, on June 17, 2016, the Company signed a definitive agreement to sell its Chemetall Surface Treatment business to BASF SE. This business, a separate reportable segment, is classified as discontinued operations and its results are excluded from segment results for all periods presented. As a result, our three reportable segments include Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Each segment has a dedicated team of sales, research and development, process engineering, manufacturing and sourcing, and business strategy personnel and has full accountability for improving execution through greater asset and market focus, agility and responsiveness. The new business structure aligns with the markets and customers we serve through each of the segments. The new structure also facilitates the continued standardization of business processes across the organization, and is consistent with the manner in which information is presently used internally by the Company’s chief operating decision maker to evaluate performance and make resource allocation decisions. Summarized financial information concerning our reportable segments is shown in the following tables. Results for 2015 have been recast to reflect the change in segments noted above. The “All Other” category comprises three operating segments that do not fit into any of our core businesses subsequent to the acquisition of Rockwood: minerals-based flame retardants and specialty chemicals, fine chemistry services and metal sulfides. During the first quarter of 2016 , we completed the sales of the metal sulfides business and the minerals-based flame retardants and specialty chemicals businesses. For additional information about these businesses, see Note 3, “Divestitures.” The Corporate category is not considered to be a segment and includes corporate-related items not allocated to the reportable segments. Pension and OPEB service cost (which represents the benefits earned by active employees during the period) and amortization of prior service cost or benefit are allocated to the reportable segments, All Other, and Corporate, whereas the remaining components of pension and OPEB benefits cost or credit (“Non-operating pension and OPEB items”) are included in Corporate. Segment data includes intersegment transfers of raw materials at cost and allocations for certain corporate costs. The Company’s chief operating decision maker uses earnings before interest, taxes, depreciation and amortization, as adjusted on a consistent basis for certain non-recurring or unusual items such as acquisition and integration related costs, utilization of inventory markup, gains or losses on sales of businesses, restructuring charges, facility divestiture charges, non-operating pension and OPEB items and other significant non-recurring items (“adjusted EBITDA”), in a balanced manner and on a segment basis to assess the ongoing performance of the Company’s business segments and to allocate resources. In addition, management uses adjusted EBITDA for business planning purposes and as a significant component in the calculation of performance-based compensation for management and other employees. The Company has reported adjusted EBITDA because management believes it provides transparency to investors and enables period-to-period comparability of financial performance. Adjusted EBITDA is a financial measure that is not required by, or presented in accordance with, U.S. GAAP. Adjusted EBITDA should not be considered as an alternative to Net income (loss) attributable to Albemarle Corporation, the most directly comparable financial measure calculated and reported in accordance with U.S. GAAP, or any other financial measure reported in accordance with U.S. GAAP. Three Months Ended Nine Months Ended 2016 2015 2016 2015 (In thousands) Net sales: Lithium and Advanced Materials $ 240,424 $ 208,820 $ 689,950 $ 620,597 Bromine Specialties 194,496 190,716 597,912 604,267 Refining Solutions 190,453 185,102 539,044 528,841 All Other 28,272 102,224 150,987 337,997 Corporate 365 6,354 2,655 12,117 Total net sales $ 654,010 $ 693,216 $ 1,980,548 $ 2,103,819 Adjusted EBITDA: Lithium and Advanced Materials $ 91,719 $ 77,408 $ 260,861 $ 234,988 Bromine Specialties 51,807 58,801 179,977 180,431 Refining Solutions 64,960 54,517 181,620 144,910 All Other 5,470 6,262 14,810 29,540 Corporate (25,627 ) (16,307 ) (66,435 ) (8,350 ) Total adjusted EBITDA $ 188,329 $ 180,681 $ 570,833 $ 581,519 See below for a reconciliation of adjusted EBITDA, the non-GAAP financial measure, to Net income (loss) attributable to Albemarle Corporation, the most directly comparable financial measure calculated and reported in accordance with U.S. GAAP, (in thousands): Lithium and Advanced Materials Bromine Specialties Refining Solutions Reportable Segments Total All Other Corporate Consolidated Total Three months ended September 30, 2016 Net income (loss) attributable to Albemarle Corporation $ 66,166 $ 41,621 $ 55,981 $ 163,768 $ 3,806 $ (39,354 ) $ 128,220 Depreciation and amortization 25,553 10,186 8,979 44,718 1,664 1,592 47,974 Acquisition and integration related costs (a) — — — — — 6,749 6,749 Interest and financing expenses — — — — — 15,946 15,946 Income tax expense — — — — — 12,394 12,394 Income from discontinued operations (net of tax) — — — — — (23,185 ) (23,185 ) Non-operating pension and OPEB items — — — — — (231 ) (231 ) Other (b) — — — — — 462 462 Adjusted EBITDA $ 91,719 $ 51,807 $ 64,960 $ 208,486 $ 5,470 $ (25,627 ) $ 188,329 Three months ended September 30, 2015 Net income (loss) attributable to Albemarle Corporation $ 38,498 $ 49,395 $ 45,713 $ 133,606 $ 617 $ (68,831 ) $ 65,392 Depreciation and amortization 22,076 9,406 8,804 40,286 5,645 2,712 48,643 Utilization of inventory markup (c) 16,834 — — 16,834 — — 16,834 Restructuring and other, net (d) — — — — — (6,804 ) (6,804 ) Acquisition and integration related costs (a) — — — — — 36,514 36,514 Interest and financing expenses — — — — — 19,294 19,294 Income tax expense — — — — — 13,144 13,144 Income from discontinued operations (net of tax) — — — — — (11,030 ) (11,030 ) Non-operating pension and OPEB items — — — — — (1,306 ) (1,306 ) Adjusted EBITDA $ 77,408 $ 58,801 $ 54,517 $ 190,726 $ 6,262 $ (16,307 ) $ 180,681 Nine months ended September 30, 2016 Net income (loss) attributable to Albemarle Corporation $ 186,373 $ 150,221 $ 154,767 $ 491,361 $ 133,012 $ (582,788 ) $ 41,585 Depreciation and amortization 74,488 29,756 26,853 131,097 5,629 4,562 141,288 (Gain) loss on sales of businesses, net (e) — — — — (123,831 ) 1,533 (122,298 ) Acquisition and integration related costs (a) — — — — — 44,337 44,337 Interest and financing expenses — — — — — 46,860 46,860 Income tax expense — — — — — 61,535 61,535 Loss from discontinued operations (net of tax) — — — — — 357,843 357,843 Non-operating pension and OPEB items — — — — — (779 ) (779 ) Other (b) — — — — — 462 462 Adjusted EBITDA $ 260,861 $ 179,977 $ 181,620 $ 622,458 $ 14,810 $ (66,435 ) $ 570,833 Nine months ended September 30, 2015 Net income (loss) attributable to Albemarle Corporation $ 88,219 $ 154,353 $ 119,513 $ 362,085 $ 9,644 $ (211,075 ) $ 160,654 Depreciation and amortization 67,530 26,078 25,397 119,005 16,867 6,933 142,805 Utilization of inventory markup (c) 79,239 — — 79,239 3,029 — 82,268 Restructuring and other, net (d) — — — — — (6,804 ) (6,804 ) Acquisition and integration related costs (a) — — — — — 117,171 117,171 Interest and financing expenses — — — — — 62,193 62,193 Income tax expense — — — — — 41,780 41,780 Income from discontinued operations (net of tax) — — — — — (19,074 ) (19,074 ) Non-operating pension and OPEB items — — — — — (3,915 ) (3,915 ) Other (f) — — — — — 4,441 4,441 Adjusted EBITDA $ 234,988 $ 180,431 $ 144,910 $ 560,329 $ 29,540 $ (8,350 ) $ 581,519 (a) See Note 2, “Acquisitions,” for additional information. (b) Includes the write-off of fixed assets of $1.4 million included in Research and development expenses, partially offset by a net gain of $0.9 million on the sales of properties included in Other income, net. (c) In connection with the acquisition of Rockwood, the Company valued Rockwood’s existing inventory at fair value as of the Acquisition Closing Date, which resulted in a markup of the underlying net book value of the inventory totaling approximately $103.4 million . The inventory markup was expensed over the estimated remaining selling period. For the three-month and nine-month periods ended September 30, 2015 , $7.7 million and $55.4 million , respectively, was included in Cost of goods sold, and Equity in net income of unconsolidated investments was reduced by $9.1 million and $26.9 million , respectively, related to the utilization of the inventory markup. (d) Gain recognized upon the sale of land in Avonmouth, UK, which was utilized by the phosphorus flame retardants business we exited in 2012. (e) See Note 3, “Divestitures,” for additional information. (f) Financing-related fees expensed in connection with the acquisition of Rockwood. |